Mitochondria as a target for neuroprotection

被引：3

作者：

Silachev D.N. ^{[1
,3
]}

Zorova L.D. ^{[2
,3
]}

Usatikova E.A. ^{[1
,3
]}

Pevzner I.B. ^{[1
,3
]}

Babenko V.A. ^{[3
]}

Gulyaev M.V. ^{[4
]}

Pirogov Y.A. ^{[5
]}

Antonenko Y.N. ^{[1
,3
]}

Plotnikov E.Y. ^{[1
,3
]}

Zorov D.B. ^{[1
,3
]}

机构：

[1] Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Leninskie Gory 1, Moscow

[2] International Laser Center, Lomonosov Moscow State University, Leninskie Gory 1, Moscow

[3] Lomonosov Moscow State University, Leninskie Gory 1, Moscow

[4] Lomonosov Moscow State University, Lomonosovsky pr. 31, Moscow

[5] Lomonosov Moscow State University, Leninskye Gory 1, Moscow

来源：

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology | 2016年 / 10卷 / 1期

基金：

俄罗斯基础研究基金会;

关键词：

antioxidants; cerebral ischemia; mitochondria; neuroprotection; preconditioning; uncouplers;

D O I：

10.1134/S1990747815050128

中图分类号：

学科分类号：

摘要：

Despite all the efforts of modern medical and biomedical sciences, the effective therapeutic treatments that would restore the brain functions lost after stroke have not been found yet. At the same time, experimental preclinical studies revealed an arsenal of effectors having potential for clinical applications. Identification of the key signaling pathways, both damaging and protective, can accelerate the development and implementation of new effective neuroprotectors. One of the key elements of these pathways is mitochondrion. In this context, we studied various therapeutic approaches to the treatment and prevention of cerebral ischemia, which are aimed at modulation of mitochondrial functions. The spectrum of tested neuroprotectors included antioxidants, uncouplers of respiration and phosphorylation, as well as ischemic, remote, and pharmacological preconditioning. Their efficacy and therapeutic windows were compared and the possibility of combining different methods in order to maximize their efficiency was considered. © 2016, Pleiades Publishing, Ltd.

引用

页码：28 / 36

页数：8

共 50 条

[31] Mitochondria as the memantine target
Shevtsova, E. P.
Dubova, L. G.
Kireeva, E. G.
Bachurin, S. O.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S243 - S244
[32] Mannose binding lectin as a target for neuroprotection
Orsini, F.
Zanier, E. R.
Gesuete, R.
Stravalaci, M.
De Blasio, D.
Oortwijn, B.
Mannesse, M. L. M.
Gobbi, M.
De Simoni, M. G.
MOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2200 - 2200
[33] The mitochondrial permeability transition as a target for neuroprotection
Kristal, BS
Stavrovskaya, IG
Narayanan, MV
Krasnikov, BF
Brown, AM
Beal, MF
Friedlander, RM
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2004, 36 (04) : 309 - 312
[34] Inflammation in stroke - A potential target for neuroprotection ?
Priller, J
Dirnagl, U
NEUROINFLAMMATION - FROM BENCH TO BEDSIDE, 2002, 39 : 133 - 157
[35] Oxidative stress, mitochondria, and approaches to neuroprotection - Questions and answers
NEUROPROTECTIVE AGENTS, 2003, 993 : 345 - 349
[36] Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease
Yadav, Anuradha
Agarwal, Swati
Tiwari, Shashi Kant
Chaturvedi, Rajnish K.
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (35) : 5558 - 5573
[37] Mitochondria in neurodegeneration: role in neural cell death and neuroprotection
Naoi, Makoto
Maruyama, Wakako
JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (10) : 1471 - 1471
[38] PKCβII translocation to mitochondria as a component of endogenous neuroprotection
Krupska, O.
Sarnowska, A.
Zablocka, B.
Beresewicz, M.
FEBS JOURNAL, 2017, 284 : 243 - 244
[39] Mitochondria in cell death: novel targets for neuroprotection and cardioprotection
Mattson, MP
Kroemer, G
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (05) : 196 - 205
[40] Perspectives of drug-based neuroprotection targeting mitochondria
Procaccio, V.
Bris, C.
de la Barca, J. M. Chao
Oca, F.
Chevrollier, A.
Amati-Bonneau, P.
Bonneau, D.
Reynier, P.
REVUE NEUROLOGIQUE, 2014, 170 (05) : 390 - 400

← 1 2 3 4 5 →